KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Genomind®, the leader in comprehensive genetics and digital mental health services, has pioneered a new level of specificity and accuracy for cheek swab-based ...

Fluidigm () today announced an agreement to develop and supply a customized version of its high-throughput library prep system to the DKMS (Deutsche Knochenmarkspenderdatei gemeinnützige Gesellschaft ...

CareDx (CDNA), The Transplant Company and Dovetail Genomics, a leader in the field of genomic solutions announced a strategic partnership to drive the next wave of innovation in HLA genotyping for ...

Evaluation of previous HLA typing for the Fred Hutchinson Cancer Center Clinical Coordinator Office prior to consult appointments (includes review of CIL and outside lab typing). Review and advice on ...

Next-generation sequencing (NGS) is quickly becoming the go-to tool for testing labs looking to bring on additional tests requiring smaller tissue samples, reduced time to results, and increased ...

Targeted NGS has been instrumental in helping the healthcare community deliver on the promise of precision medicine. The Ion Torrent Genexus Integrated Sequencer has enabled targeted genomic ...

The human leukocyte antigen (HLA) system has an important role in the regulation of the immune system; the HLA recognizes cells as ‘non-self’ or ‘self’ to prevent the body from attacking its own cells ...

HLA testing is being used in the field of pharmacogenomics to find the possible drug hypersensitivity reaction. 01 has been identified as a possible marker for abacavir-induced hypersensitivity, and ...

Illumina said today it has acquired Conexio-Genomics, a developer of human leukocyte antigen (HLA) typing solutions, for an undisclosed price. The acquisition comes about a year after the companies ...

Initial focus on non-diagnostic testing with Next Generation Sequencing (NGS) for infection control, outbreak management and research First commercial orders received and processed Vienna, Austria, ...

The global HLA typing market is expected to expand at a compound annual growth rate (CAGR) of approximately 6% during the forecast period. Market growth is driven by the rising demand for organ and ...